Liu Lijie, Shao Chuan, Li Lujia, Wu Nan
Department of Health Care, People's Liberation Army Navy 971 Hospital, Qingdao, 266071, People's Republic of China.
Department of Neurosurgery, Chongqing General Hospital, Chongqing University, Chongqing, 401147, People's Republic of China.
Int J Womens Health. 2025 Jul 22;17:2233-2244. doi: 10.2147/IJWH.S530529. eCollection 2025.
Less is known about the link between mortality and endometriosis, an often chronic, inflammatory gynecologic condition. We assessed the association between endometriosis and all-cause and cause-specific mortality using a retrospective cohort study design based on data from the National Health and Nutrition Examination Survey (NHANES) 1999-2006.
Both crude and multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for endometriosis and age at endometriosis with all-cause mortality were estimated using weighted Cox proportional hazards regression. Moreover, we also performed an exploratory analysis assessing the relationship between endometriosis and mortality from cancer and cardiovascular disease (CVD).
Between 1999 and 2006, a cohort of 5552 women aged 20 to 54 years was studied, representing a weighted population of approximately 66.07 million. Over a median follow-up duration of 16.75 years, 290 participants died from various causes, which extrapolates to an estimated 3,411,632 female deaths in the broader population. A non-significant association was identified between endometriosis and all-cause mortality (HR 1.51, 95% CI: 0.97-2.34, = 0.066), cancer (HR 1.45, 95% CI: 0.76-2.78, = 0.260), or CVD (HR 1.75, 95% CI: 0.65-4.73, = 0.271) mortality. When accounting for the age at endometriosis was diagnosed, the association was significant only among women diagnosed at age ≤30 years (HR = 1.87, 95% CI: 1.15-3.03, = 0.011 for all-cause mortality; HR = 4.37, 95% CI: 1.54-12.36, = 0.005 for CVD mortality) and was not significant for those diagnosed after age 30 years.
In conclusion, women diagnosed with endometriosis at a younger age may be associated with an increased risk of mortality.
子宫内膜异位症是一种常见的慢性炎症性妇科疾病,关于其与死亡率之间的联系,人们了解较少。我们基于1999 - 2006年美国国家健康与营养检查调查(NHANES)的数据,采用回顾性队列研究设计,评估子宫内膜异位症与全因死亡率及特定病因死亡率之间的关联。
使用加权Cox比例风险回归估计子宫内膜异位症及子宫内膜异位症确诊时年龄与全因死亡率的粗风险比(HR)和多变量调整风险比以及95%置信区间(CI)。此外,我们还进行了一项探索性分析,评估子宫内膜异位症与癌症及心血管疾病(CVD)死亡率之间的关系。
在1999年至2006年期间,对5552名年龄在20至54岁之间的女性进行了研究,代表加权人口约6607万。在中位随访期16.75年期间,290名参与者死于各种原因,据此推算在更广泛人群中估计有3411632名女性死亡。未发现子宫内膜异位症与全因死亡率(HR = 1.51,95% CI:0.97 - 2.34,P = 0.066)、癌症(HR = 1.45,95% CI:0.76 - 2.78,P = 0.260)或CVD死亡率(HR = 1.75,95% CI:0.65 - 4.73,P = 0.271)之间存在显著关联。当考虑子宫内膜异位症确诊时的年龄时,该关联仅在确诊年龄≤30岁的女性中显著(全因死亡率HR = 1.87,95% CI:1.15 - 3.03,P = 0.011;CVD死亡率HR = 4.37,95% CI:1.54 - 12.36,P = 0.005),而在30岁以后确诊的女性中不显著。
总之,年轻时被诊断为子宫内膜异位症的女性可能与死亡风险增加有关。